Aptamer Group trades on AIM market of the London Stock Exchange
A YORK-based biotechnology firm has started trading on London’s junior stock market - valued at about £80m.
Source: yorkpress.co.uk
Page 3 - David Bunka News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David Bunka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Bunka Today - Breaking & Trending Today
Investegate |Aptamer Group PLC Announcements | Aptamer Group PLC: Admission to trading on AIM
Investegate announcements from Aptamer Group PLC, Admission to trading on AIM
Source: investegate.co.uk
UK biotech firm Aptamer to float valued at £80.7m
York-based company makes synthetic antibodies for pharmaceutical firms including AstraZeneca
Source: theguardian.com
Investegate |Aptamer Group PLC Announcements | Aptamer Group PLC: Proposed Placing on AIM
Investegate announcements from Aptamer Group PLC, Proposed Placing on AIM
Source: investegate.co.uk
Aptamer Group Ltd appoints Jordan Clark as Chief Commercial Officer
Aptamer Group, the developer of Optimer biotherapeutics and diagnostics, is pleased to announce the appointment of Jordan Clark as Chief Commercial Officer at Aptamer Group with immediate effect.
Source: news-medical.net